Found 4 results
Filters: Author is D.L. Man  [Clear All Filters]
L. P. Zhou, Luan, H., Dong, X. H., Jin, G. J., Man, D. L., and Shang, H., Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis, vol. 10, pp. 3674-3688, 2011.
Bae SJ, Kim JW, Kang H, Hwang SG, et al. (2008). Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 28: 1271-1276. PMid:18505065   Brogan IJ, Khan N, Isaac K, Hutchinson JA, et al. (1999). Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 60: 1245-1249.   Cacev T, Loncar B, Seiwerth S, Spavanti S, et al. (2008). Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA Cell Biol. 27: 569-574. PMid:18613756   Cao C, Ying T, Fang JJ, Sun SF, et al. (2010). Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Med. Oncol. [Ahead of print].   Carmeliet P and Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407: 249-257. PMid:11001068   Chae YS, Kim JG, Sohn SK, Cho YY, et al. (2008). Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J. Korean Med. Sci. 23: 421-427. PMid:18583877 PMCid:2526538   Clapper ML (2000). Genetic polymorphism and cancer risk. Curr. Oncol. Rep. 2: 251-256. PMid:11122850   Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, et al. (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol. Carcinog. 48: 563-569. PMid:19009560   Des Guetz G, Uzzan B, Nicolas P, Cucherat M, et al. (2006). Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94: 1823-1832. PMid:16773076 PMCid:2361355   Duthie SJ (2011). Epigenetic modifications and human pathologies: cancer and CVD. Proc. Nutr. Soc. 70: 47-56. PMid:21067630   Ferrara N (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77: 527-543. PMid:10494799   Ferrara N (2000). Vascular endothelial growth factor and the regulation of angiogenesis. Recent. Prog. Horm. Res. 55: 15-35. PMid:11036931   Folkman J and Shing Y (1992). Angiogenesis. J. Biol. Chem. 267: 10931-10934. PMid:1375931   Gasparini G, Toi M, Gion M, Verderio P, et al. (1997). Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89: 139-147. PMid:8998183   Hanahan D and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. PMid:12111919   Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, et al. (2008). Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J. Cancer Res. Clin. Oncol. 134: 591-595. PMid:17938959   Knight JC (2005). Regulatory polymorphisms underlying complex disease traits. J. Mol. Med. 83: 97-109. PMid:15592805 PMCid:3132451   Kuramochi H, Hayashi K, Uchida K, Miyakura S, et al. (2006). Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer. Clin. Cancer Res. 12: 29-33. PMid:16397020   Liu L, Liu L, Zeng F, Wang K, et al. (2010). Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J. Cancer Res. Clin. Oncol. 137: 1027-1036. PMid:21174216   Maltese P, Canestrari E, Ruzzo A, Graziano F, et al. (2009). VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int. J. Colorectal Dis. 24: 165-170. PMid:18830612   Park HM, Hong SH, Kim JW, Oh D, et al. (2007). Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer. Anticancer Res. 27: 2535-2539. PMid:17695550   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. PMid:16467236   Ponder BA (2001). Cancer genetics. Nature 411: 336-341. PMid:11357140   Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, et al. (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 37: 443-448. PMid:11146397   Rothwell PM, Wilson M, Elwin CE, Norrving B, et al. (2010). Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376: 1741-1750.   Saad RS, Kordunsky L, Liu YL, Denning KL, et al. (2006). Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod. Pathol. 19: 1317-1323. PMid:16799477   Schott RJ and Morrow LA (1993). Growth factors and angiogenesis. Cardiovasc. Res. 27: 1155-1161. PMid:7504584   Taby R and Issa JP (2010). Cancer epigenetics. CA Cancer J. Clin. 60: 376-392. PMid:20959400   Takahashi Y, Kitadai Y, Bucana CD, Cleary RK, et al. (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55: 3964-3968. PMid:7664263   Tanigawa N, Amaya H, Matsumura M, Lu C, et al. (1997). Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res. 57: 1043-1046. PMid:9067267   van Engeland M, Derks S, Smits KM, Meijer GA, et al. (2011). Colorectal cancer epigenetics: complex simplicity. J. Clin. Oncol. 29: 1382-1391. PMid:21220596   Vandenbroucke JP, von EE, Altman DG, Gotzsche PC, et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835. PMid:18049195   Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, de Bruijn DR, et al. (2010). The epigenetics of (hereditary) colorectal cancer. Cancer Genet. Cytogenet. 203: 1-6. PMid:20951312   Viechtbauer W (2007). Confidence intervals for the amount of heterogeneity in meta-analysis. Stat. Med. 26: 37-52. PMid:16463355   Vincenti V, Cassano C, Rocchi M and Persico G (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93: 1493-1495. PMid:8608615   Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235. PMid:10930302   Weitz J, Koch M, Debus J, Höhler T, et al. (2005). Colorectal cancer. Lancet 365: 153-165.   Wu GY, Wang XM, Keese M, Hasenberg T, et al. (2006). Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage. Zhonghua Wai Ke Za Zhi 44: 1505-1507. PMid:17349182   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. PMid:15593093